Recent advances in the management and treatment of GI and hepatic diseases associated with HIV: Part 2.
Boyle
B A
BA
Department of International Medicine and Infectious Disease, New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, USA.
D000547:Amantadine / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D006678:HIV / Q000187:drug effects; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006509:Hepatitis B / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D006526:Hepatitis C / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use; D012307:Risk Factors
D000998:Antiviral Agents; D016898:Interferon-alpha; D019259:Lamivudine; D000547:Amantadine